2007
DOI: 10.2215/cjn.01240307
|View full text |Cite
|
Sign up to set email alerts
|

Routine Use of Ambulatory Blood Pressure Monitoring in Potential Living Kidney Donors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 27 publications
0
11
0
Order By: Relevance
“…On the contrary, hypertensive blood pressure readings without confirmation by 24 h blood pressure recording may reflect white coat hypertension. 30 31 In our study, all new diagnoses of hypertension had to be verified by 24 h ambulatory blood pressure recording. Blood pressure values in the normal range were only accepted as ‘normal’ if a list of drugs taken the same day was reported to SOL-DHR.…”
Section: Discussionmentioning
confidence: 99%
“…On the contrary, hypertensive blood pressure readings without confirmation by 24 h blood pressure recording may reflect white coat hypertension. 30 31 In our study, all new diagnoses of hypertension had to be verified by 24 h ambulatory blood pressure recording. Blood pressure values in the normal range were only accepted as ‘normal’ if a list of drugs taken the same day was reported to SOL-DHR.…”
Section: Discussionmentioning
confidence: 99%
“…A number of studies have noted the value of ABPM when clinic blood pressures are in the hypertensive range among prospective living kidney donors [6]. Such studies have noted that among potential donors who have elevated blood pressure during clinic evaluation, 30–60% of those subjects will be in the normotensive range when studied with ABPM [5,6]. Our study adds to this literature by observing that this white coat effect is not limited to just those with hypertensive clinic blood pressures.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, clinic-based blood pressures do not appear to characterize fully future cardiovascular risk on several fronts [4]. Moreover, limited data suggests a high incidence of white coat hypertension during the kidney donation evaluation [5,6]. However, to our knowledge, no data details the persistence of white coat effect after kidney donation.…”
Section: Introductionmentioning
confidence: 99%
“…There were no studies in peritoneal dialysis patients, but three studies reported a prevalence between 16% [31] and 39% [32] in renal transplant recipients. There was one study in prospective renal donors reporting a prevalence of 17% [33]. [35].…”
Section: The Effect Of Comorbiditiesmentioning
confidence: 99%